DD237659A5 - Verfahren zur herstellung von neuen 1,2,3,4,6,7-12,12b-octahydro-indolo(2,3-a)-chinolisin-1-yl-alkancarbonsaeureamiden - Google Patents

Verfahren zur herstellung von neuen 1,2,3,4,6,7-12,12b-octahydro-indolo(2,3-a)-chinolisin-1-yl-alkancarbonsaeureamiden Download PDF

Info

Publication number
DD237659A5
DD237659A5 DD85281462A DD28146285A DD237659A5 DD 237659 A5 DD237659 A5 DD 237659A5 DD 85281462 A DD85281462 A DD 85281462A DD 28146285 A DD28146285 A DD 28146285A DD 237659 A5 DD237659 A5 DD 237659A5
Authority
DD
German Democratic Republic
Prior art keywords
ethyl
mol
broad
yield
quinolysin
Prior art date
Application number
DD85281462A
Other languages
German (de)
English (en)
Inventor
Soti
Szantay
Incze
Balogh
Ezer
Matuz
Szporny
Hajos
Kuthi
Original Assignee
�������@������@����������@����@��Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@������@����������@����@��Kk�� filed Critical �������@������@����������@����@��Kk��
Publication of DD237659A5 publication Critical patent/DD237659A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD85281462A 1984-10-05 1985-10-04 Verfahren zur herstellung von neuen 1,2,3,4,6,7-12,12b-octahydro-indolo(2,3-a)-chinolisin-1-yl-alkancarbonsaeureamiden DD237659A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU843776A HU191454B (en) 1984-10-05 1984-10-05 Process for producing amides of oktahydro-indolo/2,3-a/quinolyzin-1-yl-alkanecarboxylic acids and pharmaceutically acceptable acid additional salts thereof

Publications (1)

Publication Number Publication Date
DD237659A5 true DD237659A5 (de) 1986-07-23

Family

ID=10965440

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85281462A DD237659A5 (de) 1984-10-05 1985-10-04 Verfahren zur herstellung von neuen 1,2,3,4,6,7-12,12b-octahydro-indolo(2,3-a)-chinolisin-1-yl-alkancarbonsaeureamiden

Country Status (23)

Country Link
US (1) US4782052A (xx)
EP (1) EP0177361A3 (xx)
JP (1) JPS61126086A (xx)
KR (1) KR860003254A (xx)
CN (1) CN85109716A (xx)
AU (1) AU578314B2 (xx)
CA (1) CA1267145A (xx)
DD (1) DD237659A5 (xx)
DK (1) DK453485A (xx)
ES (1) ES8701176A1 (xx)
FI (1) FI853867L (xx)
GR (1) GR852410B (xx)
HU (1) HU191454B (xx)
IL (1) IL76579A0 (xx)
IN (1) IN162609B (xx)
NO (1) NO161857B (xx)
NZ (1) NZ213710A (xx)
PH (1) PH23265A (xx)
PL (1) PL145678B1 (xx)
PT (1) PT81256B (xx)
SU (1) SU1470193A3 (xx)
YU (1) YU159085A (xx)
ZA (1) ZA857687B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582663B2 (en) * 1985-08-10 1989-04-06 John Wyeth & Brother Limited Sulphonamides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565804A (en) * 1975-10-28 1980-04-23 Inverni Della Beffa Spa Alkaloid derivatives
ZA786426B (en) * 1977-11-25 1979-10-31 Scras New indulo(2,3-a)quinolizidines,preparation and therapeutic use
HU178700B (en) * 1978-02-10 1982-06-28 Richter Gedeon Vegyeszet Process for preparing 1,1-disubstituted octahydro-indolo/2,3-a/-quinolizines
US4353911A (en) * 1979-07-20 1982-10-12 Andre Buzas Indolo(2,3-a)quinolizidines, useful in increasing femoral and vertebral blood flow
HU186891B (en) * 1981-06-12 1985-10-28 Richter Gedeon Vegyeszet Process for producing esters of apovincaminic acid
EP0079411B1 (fr) * 1981-11-18 1987-02-04 Thal, Claude Dérivés d'indoloquinolizine, leur procédé de préparation et leur application en thérapeutique
DE3204960A1 (de) * 1982-02-12 1983-08-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Corynanthein-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
HU194221B (en) * 1985-04-19 1988-01-28 Richter Gedeon Vegyeszet Process for preparing novel octahydro-indolo/2,3-a/quinoline derivative and pharmaceutical comprising this compound
HU195214B (en) * 1985-04-19 1988-04-28 Richter Gedeon Vegyeszet Process for producing 12b-substituted-1-(hydroxymethyl)-octahydro-indolo /2,3-a/ quinolizine derivatives and pharmaceutical preparations comprising these compounds

Also Published As

Publication number Publication date
JPS61126086A (ja) 1986-06-13
PL145678B1 (en) 1988-10-31
FI853867L (fi) 1986-04-06
AU4832985A (en) 1986-04-10
CA1267145A (en) 1990-03-27
PL255646A1 (en) 1986-10-21
PT81256A (en) 1985-11-01
AU578314B2 (en) 1988-10-20
NZ213710A (en) 1988-08-30
DK453485D0 (da) 1985-10-04
NO853936L (no) 1986-04-07
NO161857B (no) 1989-06-26
PT81256B (pt) 1987-10-20
US4782052A (en) 1988-11-01
IN162609B (xx) 1988-06-18
DK453485A (da) 1986-04-06
GR852410B (xx) 1986-02-04
SU1470193A3 (ru) 1989-03-30
CN85109716A (zh) 1986-10-08
PH23265A (en) 1989-06-23
KR860003254A (ko) 1986-05-21
EP0177361A3 (en) 1987-09-02
ES8701176A1 (es) 1986-11-16
IL76579A0 (en) 1986-02-28
YU159085A (en) 1988-04-30
FI853867A0 (fi) 1985-10-04
HU191454B (en) 1987-02-27
ZA857687B (en) 1986-05-28
ES547605A0 (es) 1986-11-16
EP0177361A2 (en) 1986-04-09

Similar Documents

Publication Publication Date Title
DE3875361T2 (de) Thiazolidin-derivate.
DE3786229T2 (de) Prolinalderivate.
DE69107459T2 (de) Benzosäure substituierte derivate mit kardiovasculärer wirkung.
DE3306006C2 (xx)
DE3718450A1 (de) Biphenyl-hydroxamsaeure-derivate
EP0656353A1 (de) Aminochinolin-Derivate mit einer Wirksamkeit gegen Malariaerreger
DE3017684C2 (xx)
DE2356903A1 (de) Verfahren zur herstellung substituierter chromon-3-carbonitrile, -carboxamide und -carbonsaeuren
AT371461B (de) Verfahren zur herstellung neuer benzopyranderivate und deren salze
EP0665228B1 (de) Neue 3-Phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen enthaltende Arzneimittel
DE3721223C2 (xx)
DE2557145C3 (de) Tyrosinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DD237659A5 (de) Verfahren zur herstellung von neuen 1,2,3,4,6,7-12,12b-octahydro-indolo(2,3-a)-chinolisin-1-yl-alkancarbonsaeureamiden
DE2413125C2 (de) Indolylacetylaminosäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneipräparate
DE3424586A1 (de) 3-aminocarbonylmethoxy-5-phenyl-pyrazol-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0400499B1 (de) Neue Acylaminosäurederivate enthaltende Arzneimittel und Diätetika
EP0123700A1 (de) Substituierte Picolinsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
AT391316B (de) Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2716172C2 (de) Bis(6-[(hexahydro-1H-azepin-1-yl)-methylenamino]-penicillanoyloxy)-methan, seine Herstellung und dieses enthaltendes Arzneimittel
DE3034005C2 (de) Indolessigsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
EP0091045B1 (de) 2-Pyrrolin-3-carbonitril-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP0046554B1 (de) N-substituierte Brenztraubensäurehydrazone, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
EP0334014A2 (de) Substituierte Imidazolinone und Imidazolinthione
DE2559928C2 (de) N-Aroyl-L-phenylalanyl-L-tyrosine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3245950A1 (de) Verfahren zur herstellung substituierter pyridine

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee